Mark P. Lappe
2021
In 2021, Mark P. Lappe earned a total compensation of $4.7M as Chief Executive Officer and President at Inhibrx, a 439% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $325,000 |
|---|---|
| Option Awards | $3,687,792 |
| Salary | $650,000 |
| Other | $19,281 |
| Total | $4,682,073 |
Lappe received $3.7M in option awards, accounting for 79% of the total pay in 2021.
Lappe also received $325K in non-equity incentive plan, $650K in salary and $19.3K in other compensation.
Rankings
In 2021, Mark P. Lappe's compensation ranked 2,823rd out of 12,415 executives tracked by ExecPay. In other words, Lappe earned more than 77.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,823 out of 12,415 | 77th |
Division Manufacturing | 1,121 out of 5,508 | 80th |
Major group Chemicals And Allied Products | 443 out of 2,378 | 81st |
Industry group Drugs | 387 out of 2,099 | 82nd |
Industry Biological Products, Except Diagnostic Substances | 113 out of 449 | 75th |
Source: SEC filing on April 13, 2022.
Lappe's colleagues
We found three more compensation records of executives who worked with Mark P. Lappe at Inhibrx in 2021.